Home ProductsAPI Powder

Treat High Blood Pressure White Powder CAS 83915-83-7 Lisinopril Dihydrate

Certification
China Wuhan Senwayer Century Chemical Co., Ltd. certification
China Wuhan Senwayer Century Chemical Co., Ltd. certification
Customer Reviews
everything was great. friendly and understanding representative and fast shipping(compared to other items on here). my shoulder feels much stronger and healthier after only one and a half weeks.

—— Terry Smith

Superb Excellence is all I can say about this Company and its products. I will continue to buy from this company. The service is excellent and the product matches the service. Thanks for the great product and service. I will be ordering from you really soon.

—— Brant huges

Love it I’ve been using it for a long time

—— Drew

I'm Online Chat Now

Treat High Blood Pressure White Powder CAS 83915-83-7 Lisinopril Dihydrate

Treat High Blood Pressure White Powder CAS 83915-83-7 Lisinopril Dihydrate
Treat High Blood Pressure White Powder CAS 83915-83-7 Lisinopril Dihydrate

Large Image :  Treat High Blood Pressure White Powder CAS 83915-83-7 Lisinopril Dihydrate

Product Details:
Place of Origin: China
Brand Name: Senwayer
Certification: ISO/GMP/USP/BP
Model Number: 83915-83-7
Payment & Shipping Terms:
Minimum Order Quantity: 100g
Price: Price depends on quantity
Packaging Details: foil bag, drum, vials
Delivery Time: 4-5days
Payment Terms: Western union/ money gram/bitcoin/bank transfer/Credit card
Supply Ability: 1000 g per week

Treat High Blood Pressure White Powder CAS 83915-83-7 Lisinopril Dihydrate

Description
Product Name: Lisinopril Dihydrate Other Name: Lisinopril
CAS No: 83915-83-7 Purity: 99%min
Shelf Life: 2 Years Application: Treat High Blood Pressure
Sample: Available Storage: Cool And Dry Place
Appearance: White Crystalline Powder
High Light:

83915-83-7 Lisinopril Dihydrate

,

Lisinopril Dihydrate White Powder

,

High Blood Pressure Lisinopril Dihydrate

Treat High Blood Pressure White Powder CAS 83915-83-7 Lisinopril Dihydrate

Product Introduction

Name: Lisinopril Dihydrate
English Synonym: Lisinopril
CAS number: 83915-83-7
Molecular formula: C21H31N3O5
Molecular weight: 405.49
EINECS Number: 627-033-9

 

Product Description

Melting point: 148°C
Specific rotation: 25405-120°(c=1 in 0.25M pH 6.4z in cacetate); 25436-96°(c=1 in 0.25M pH 6.4z in cacetate)
Refractive index: -45°(C=1,0.25mol/L Zinc Acetate Buffer)
Storage conditions: 2-8°C
Solubility:H2O:≥10mg/mL
Form:solid
Acidity coefficient (pKa): 2.5, 4.0, 6.7, 10.1 (at25℃)
Color:white
Stability:Hygroscopic


Product Function

Lisinopril is a third-generation angiotensin-converting enzyme inhibitor and a lysine derivative of enalapril. It was marketed in the United States in 1987 for the treatment of hypertension and is a first-line drug for anti-hypertensive disease. The pharmacological action characteristics are similar to that of Enalapril. It has a strong inhibitory effect on angiotensin-converting enzyme.

 

The inhibitory effect on ACE is 6 to 8 times that of captopril and 1 to 3 times that of benazepril. Total peripheral resistance and blood pressure can be significantly decreased, but not accompanied by reflex tachycardia. Lisinopril can reduce pulmonary wedge pressure, increase cardiac output, increase left ventricular ejection fraction, and improve cardiac function in patients with heart failure. Can increase renal blood flow, reduce renal vascular resistance, increase glomerular filtration rate. It can be used alone or in combination with other drugs to treat various degrees of hypertension and renal hypertension that cannot be treated by other antihypertensive drugs. It can also be used alone or in combination with digitalis and diuretics to treat congestive heart failure. It can also be used as adjuvant therapy for hemodynamically stable patients after acute myocardial infarction.

 

Common angiotensin-converting enzyme inhibitors (ACEIs): captopril, enalapril, benazepril, perindopril, lisinopril, cilazapril, ramipril, mida Puli, Fosin Puli. The most studied ACEI in the treatment of heart failure is enalapril, followed by captopril, and then ramipril, lisinopril and quinapril, all of which have been shown to be effective, but it is still unclear which ACEI has the best effect. There are no direct comparative studies. It has been reported that the effect of enalapril in reducing mortality is more pronounced than that of captopril, and may be stronger than that of enalapril, with longer duration, less bioavailability affected by food intake, and an increase in the plasma concentration of Ang II. Factors such as less diurnal variation are related.


Treat High Blood Pressure White Powder CAS 83915-83-7 Lisinopril Dihydrate 0

 

Contact Details
Wuhan Senwayer Century Chemical Co., Ltd.

Contact Person: kate

Tel: +8616607120890

Send your inquiry directly to us (0 / 3000)